- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02746484
ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program
ABILITY - TelerehABILITation. TechnologY-enhanced Multi-domain at Home Continuum of Care Program for People With Cognitive Impairment.
The Ability research project, funded in Italy within the Smart Cities and Smart Communities funding program (MInistry of University and Research, Operational Regional Programme, Lombardy, Axis 1, Operational Regional Programme - European Funding for Regional Development 2007-2013), aims at developing and testing the efficacy and the impact of a Personal Smart Health Community able to provide innovative trajectories for people with cognitive impairment, putting them at the core of a continuous and intertwining treatment and support from both formal (e.g. physicians) and informal (e.g. near relatives) caregivers, with special focus on home-based care.
Within this framework of the Ability project the investigators test the efficacy of the home-based motor-cognitive rehabilitation program delivered with two different approaches: the Ability platform versus the usual care program
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- diagnosed as mild AD or MCI due to AD (Albert et al, 2011) according to DSM 5 diagnostic criteria (American Psychiatric Association, 2013);
- MMSE score >18
- school attendance (≥ 3 years).
Exclusion Criteria:
- dysmetria;
- serious deficits in visual acuity, acoustic perception, and in routine communication skills.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Ability platform program
Multi-domain at home rehabilitation program delivered through the Ability platform.
|
The Ability program is an at home participant-tailored and technology-enhanced platform a) delivering tablet-based intensive (five days/a week for six weeks) motor and cognitive activities; b) monitoring from remote vital and physical health parameters (i.e., weight, Heart Rate, O2 saturation, daily steps, sleep activity).
|
Comparador activo: Usual care program
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
|
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
activities of daily living
Periodo de tiempo: change from baseline after 8 weeks (aMCI/AD subjects)
|
Activities of Daily Living Inventory (ADCS/ADL)
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
behavioral symptoms
Periodo de tiempo: change from baseline after 8 weeks (aMCI/AD subjects)
|
Neuropsychiatric Inventory (NPI) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
cognitive domain (long-term memory)
Periodo de tiempo: change from baseline after 8 weeks (aMCI/AD subjects)
|
Free and Cued Selective Recall Test (FCSRT) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
cognitive domain (language)
Periodo de tiempo: change from baseline after 8 weeks (aMCI/AD subjects)
|
Fluency score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
cognitive domain (frontal-executive functions)
Periodo de tiempo: change from baseline after 8 weeks (aMCI/AD subjects)
|
Trail Making Test (TMT) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
quality of life
Periodo de tiempo: change from baseline after 8 weeks (aMCI/AD subjects)
|
Dementia Quality of Life (D-QoL) Instrument
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
coping strategies
Periodo de tiempo: change from baseline after 8 weeks (aMCI/AD subjects)
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
global cognitive level
Periodo de tiempo: change from baseline after 12 months (aMCI/AD subjects)
|
Montreal Cognitive Asssessment (MoCA) score
|
change from baseline after 12 months (aMCI/AD subjects)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
activities of daily living
Periodo de tiempo: change from baseline after 12 months (aMCI/AD subjects)
|
Activities of Daily Living Inventory (ADCS/ADL)
|
change from baseline after 12 months (aMCI/AD subjects)
|
conversion rate MCI versus AD
Periodo de tiempo: change from baseline after 12 months (aMCI subjects)
|
conversion rate score
|
change from baseline after 12 months (aMCI subjects)
|
cognitive domain - long term memory
Periodo de tiempo: change from baseline after 12 months (aMCI/AD subjects)
|
Free and Cued Selective Recall Test (FCSRT) score
|
change from baseline after 12 months (aMCI/AD subjects)
|
cognitive domain - language
Periodo de tiempo: change from baseline after 12 months (aMCI/AD subjects)
|
Fluency score
|
change from baseline after 12 months (aMCI/AD subjects)
|
cognitive domain - frontal executive functions
Periodo de tiempo: change from baseline after 12 months
|
Trail Making Test (TMT) score
|
change from baseline after 12 months
|
quality of life
Periodo de tiempo: change from baseline after 12 months
|
Dementia Quality of Life (D-QoL) Instrument
|
change from baseline after 12 months
|
coping strategies
Periodo de tiempo: change from baseline after 12 months
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 12 months
|
caregiver quality of life
Periodo de tiempo: change from baseline after 8 weeks and after 12 months
|
Psychological Well-Being (PWB) scale
|
change from baseline after 8 weeks and after 12 months
|
caregiver coping strategies
Periodo de tiempo: change from baseline after 8 weeks and after 12 months
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 8 weeks and after 12 months
|
caregiver burden
Periodo de tiempo: change from baseline after 8 weeks and after 12 months
|
Caregiver Burden Inventory (CBI)
|
change from baseline after 8 weeks and after 12 months
|
caregiver affect
Periodo de tiempo: change from baseline after 8 weeks and after 12 months
|
Positive and Negative Affect Schedule (PANAS)
|
change from baseline after 8 weeks and after 12 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Publicaciones y enlaces útiles
Publicaciones Generales
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
- Realdon O, Rossetto F, Nalin M, Baroni I, Cabinio M, Fioravanti R, Saibene FL, Alberoni M, Mantovani F, Romano M, Nemni R, Baglio F. Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial. BMC Psychiatry. 2016 Nov 25;16(1):425. doi: 10.1186/s12888-016-1132-y.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- FdG_AD_02
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Ability platform program
-
Advocate Health CareTakeda; Lundbeck LLCTerminadoTrastorno depresivo mayorEstados Unidos
-
The University of QueenslandRestorative Outcomes Australia; Department of Education, Queensland; Queensland... y otros colaboradoresDesconocidoComportamiento antisocial | Asistencia a la escuela | Dependencia de la asistencia socialAustralia
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)TerminadoTrastorno de ansiedadCanadá
-
The University of Hong KongSydney Children's Hospitals Network; SAHKReclutamientoDesorden del espectro autistaHong Kong
-
Akdeniz UniversityAún no reclutandoAccidente cerebrovascular isquémico | EntrenamientoPavo
-
Children's HealthActivo, no reclutandoDesorden del espectro autistaEstados Unidos
-
Farhan KarimDePuy SynthesReclutamientoEnfermedad degenerativa del disco | Estenosis raquídea lumbar | Espondilolistesis lumbar | Estenosis foraminalEstados Unidos
-
Massachusetts General HospitalActivo, no reclutandoCáncer de pulmón de células no pequeñas | Mesotelioma | Cáncer de pulmón de células pequeñas | Terapia de conducta cognitivaEstados Unidos
-
Chinese University of Hong KongReclutamiento
-
Philip Winnock de Grave, MDAZ DeltaActivo, no reclutando